Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guglielmo Di Molfetta

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 1, 2024
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander diseaseNicholas J Ashton, Guglielmo Di Molfetta, Kübra Tan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 31, 2025
Inflammation biomarkers and Alzheimer's disease: A pilot study using NULISAseqGuglielmo Di Molfetta, Ilaria Pola, Kubra Tan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAnne-Brita Knapskog, Guglielmo Di Molfetta, Heidi Vihovde Sandvig, et al.
Journal of Neurochemistry|August 11, 2025
Profiling Plasma Biomarkers, Particularly pTau217 and pTau217/Aβ42, and Their Relation to Cognition in Memory Clinic PatientsMarco Bucci, Ove Almkvist, Marina Bluma, et al.
Translational Psychiatry|July 25, 2023
Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinicMarco Bucci, Marina Bluma, Irina Savitcheva, et al.
European Journal of Clinical Investigation|April 11, 2026
Prognostic Added Value of GFAP in Patients With Minor Ischemic StrokeAndrea Morotti, Mathias Sauer, Francesco Berinato, et al.
Scientific Reports|March 3, 2026
Long-COVID: assessment of circulating markers suggests no cerebral neuronal damage, neuroinflammation or systemic inflammation-a controlled studyRoald Omdal, Ole Bernt Lenning, Grete Jonsson, et al.
Ebiomedicine|December 19, 2024
Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinicsMarina Bluma, Konstantinos Chiotis, Marco Bucci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 13, 2023
Blood β-synuclein is related to amyloid PET positivity in memory clinic patientsPatrick Oeckl, Marina Bluma, Marco Bucci, et al.
Clinical Chemistry|November 13, 2025
Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?Andrea L Benedet, Burak Arslan, Kubra Tan, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 1, 2024
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander diseaseNicholas J Ashton, Guglielmo Di Molfetta, Kübra Tan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 31, 2025
Inflammation biomarkers and Alzheimer's disease: A pilot study using NULISAseqGuglielmo Di Molfetta, Ilaria Pola, Kubra Tan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAnne-Brita Knapskog, Guglielmo Di Molfetta, Heidi Vihovde Sandvig, et al.
Journal of Neurochemistry|August 11, 2025
Profiling Plasma Biomarkers, Particularly pTau217 and pTau217/Aβ42, and Their Relation to Cognition in Memory Clinic PatientsMarco Bucci, Ove Almkvist, Marina Bluma, et al.
Translational Psychiatry|July 25, 2023
Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinicMarco Bucci, Marina Bluma, Irina Savitcheva, et al.
European Journal of Clinical Investigation|April 11, 2026
Prognostic Added Value of GFAP in Patients With Minor Ischemic StrokeAndrea Morotti, Mathias Sauer, Francesco Berinato, et al.
Scientific Reports|March 3, 2026
Long-COVID: assessment of circulating markers suggests no cerebral neuronal damage, neuroinflammation or systemic inflammation-a controlled studyRoald Omdal, Ole Bernt Lenning, Grete Jonsson, et al.
Ebiomedicine|December 19, 2024
Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinicsMarina Bluma, Konstantinos Chiotis, Marco Bucci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 13, 2023
Blood β-synuclein is related to amyloid PET positivity in memory clinic patientsPatrick Oeckl, Marina Bluma, Marco Bucci, et al.
Clinical Chemistry|November 13, 2025
Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?Andrea L Benedet, Burak Arslan, Kubra Tan, et al.
Pageof 3